热门资讯> 正文
Nanox新成像系统Nanox获得FDA批准。ARC X
2025-04-17 22:49
- Nano-X Imaging (NASDAQ:NNOX) said on Thursday that it received clearance from the U.S. FDA for the Nanox.ARC X, its digital tomosynthesis device.
- The Nanox.ARC X system is used to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indications.
- Nanox will offer the Nanox.ARC X system, later this year, alongside the current Nanox.ARC, the company said.
More on Nano-X Imaging
- Nano-X Imaging Ltd. (NNOX) Q4 2024 Earnings Call Transcript
- Nano-X Imaging: When Will The Hockey Stick Growth Happen?
- Biggest stock movers Monday: COOP, HSMT, CYRX, PCVX, MRNA, NNOX and more
- SoundHound AI, Serve, Nano-X in focus as Nvidia exits stakes; cuts Arm investment
- Seeking Alpha’s Quant Rating on Nano-X Imaging
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
